SCHEMBL17546079

CC1C(O)[C@H](O[C@@H]2OC(CO)[C@H](O)C(O)[C@@H]2O)[C@H](CO)O[C@H]1O[C@@H]1C(O)[C@H](O)C(CO)O[C@@H]1OCC1O[C@@H](O[C@@H]2C(CO)O[C@@H](O[C@@H]3C(CO)O[C@@H](NC(=O)CBr)[C@@H](C)C3O)[C@@H](C)C2O)[C@H](O)C(O[C@H]2O[C@H](CO)[C@@H](O)C(O)C2O[C@@H]2OC(CO)[C@@H](O[C@@H]3OC(C)[C@H](C(O)O[C@]4(C(=O)O)C[C@@H](O)[C@@H](N)C([C@H](O)[C@H](O)CO)O4)C(O)[C@@H]3O)C(O)[C@@H]2C)[C@@H]1O

nearest known ligand 0.44

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	CD209	Q9NNX6	1/20	0.43

▸	SIGLEC7	Q9Y286	6/20	0.43

▸	SELP	P16109	2/20	0.40

▸	SELL	P14151	1/20	0.40

▸	MAG	P20916	6/20	0.38

▸	SELE	P16581	4/20	0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL17546166	0.98	SIGLEC7 (0.46)	CD209SIGLEC7SELPSELLMAG
SCHEMBL17199689	0.92	SIGLEC7 (0.50)	CD209SIGLEC7SELPSELLMAG
SCHEMBL18333611	0.92	SIGLEC7 (0.50)	CD209SIGLEC7SELPSELLMAG
SCHEMBL17546142	0.92	SIGLEC7 (0.50)	CD209SIGLEC7SELPSELLMAG
SCHEMBL16312454	0.91	SIGLEC7 (0.43)	CD209SIGLEC7SELPSELLMAG
SCHEMBL17546151	0.91	SIGLEC7 (0.50)	CD209SIGLEC7SELPSELLMAG
SCHEMBL16312498	0.90	SIGLEC7 (0.43)	CD209SIGLEC7SELPSELLMAG
SCHEMBL16312494	0.90	SIGLEC7 (0.44)	CD209SIGLEC7SELPSELLMAG
SCHEMBL17742411	0.89	SIGLEC7 (0.49)	CD209SIGLEC7SELPSELLMAG
SCHEMBL18333657	0.88	SIGLEC7 (0.44)	CD209SIGLEC7SELPSELLMAG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20160052987-A1	POLYPEPTIDE HAVING SIALYLATED SUGAR CHAINS ATTACHED THERETO	GLYTECH, INC. (JP)	2016-02-25	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20160052987-A1	POLYPEPTIDE HAVING SIALYLATED SUGAR CHAINS ATTACHED THERETO	IFNAR1, FUT4, SIGLEC7	CD209 252/4885SIGLEC7 3/4885SELP 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.